# OnCo record resolution-ctdx-first (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/resolution-ctdx-first/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "resolution-ctdx-first" ;
  schema:name "Resolution ctDx FIRST"@en ;
  schema:description "A blood test approved with adagrasib to find the KRAS G12C mutation in lung cancer when a tissue biopsy is not possible."@en ;
  schema:url <https://onco.cc/drugs/resolution-ctdx-first/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.agilent.com/en/product/liquid-biopsy/resolution-ctdx-first> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Liquid biopsy companion diagnostic test (NGS, cfDNA)" ;
  schema:alternateName "Resolution ctDx FIRST" ;
  onco:approval "US 2022: Companion diagnostic for adagrasib in KRAS G12C-mutant NSCLC (plasma)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/adagrasib/> ;
  onco:companies <https://onco.cc/companies/agilent/> ;
  onco:terms <https://onco.cc/terms/ctdna/> .